Nonsteroidal anti-inflammatory drug use in collegiate football players

Clinical Journal of Sport Medicine

Volumn 23, Issue 4, 2013, Pages 283-286

  Holmes, Nathan ^a   Cronholm, Peter F ^b   Duffy, A J ^c   Webner, David ^d  

^a Advanced Orthopedic Centers   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WIDENER UNIVERSITY   (United States)

^d St Louis University   (United States)

Author keywords

Analgesics; Anti inflammatory agents; Football; Nonsteroidal; Sports medicine

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; ASTHMA; ATHLETE; BODY MASS; CARDIOVASCULAR RISK; COLLEGE STUDENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DECREASED APPETITE; DIARRHEA; DRUG SAFETY; DRUG UTILIZATION; FOOTBALL; GAME; HEALTH SURVEY; HIGH SCHOOL STUDENT; HUMAN; MALE; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF REPORT; XEROSTOMIA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROSS-SECTIONAL STUDIES; FOOTBALL; HUMANS; MALE; YOUNG ADULT;

EID: 84879883903     PISSN: 1050642X     EISSN: 15363724     Source Type: Journal    
DOI: 10.1097/JSM.0b013e318286d0fa     Document Type: Article

References (15)

1. Alkeminders LC. Anti-inflammatory treatment of muscular injuries in sport. Sports Med. 1999;28: 383-388.
2. Mehallo CJ, Drezner JA, Bytomski Jr. Practical management: nonsteroidal antiinflammatory drug (NSAID) use in athletic injuries. Clin J Sport Med. 2006;16: 170-174.
3. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 1991;115: 787-796.
4. Huerta C, Castellsague J, Varas-Lorenzo C, et al. Nonsteroidal antiinflammatory drugs and risk of ARF in the general population. Am J Kidney Dis. 2005;45: 531-539.
5. Griffin MR, Yared A, Ray WA. Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol. 2005;151: 488-496.
6. Warden SJ. Cyclo-oxygenase-2 inhibitors: beneficial or detrimental for athletes with acute musculoskeletal injuries? Sports Med. 2005; 35: 271-283.
7. Trelle S, Reichenbach S, Wandel S, et al. Cardiovascular safety of nonsteroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011;342: c7086.
8. Bavry AA, Khaliq A, Gong Y, et al. Harmful effects of NSAIDs among patients with hypertension and coronary artery disease. Am J Med. 2011; 124: 614-620.
9. Baker J, Cotter JD, Gerrard DF, et al. Effects of indomethacin and celecoxib on renal function in athletes. Med Sci Sports Exerc. 2005;37: 712-717.
10. Warner DC, Schnepf G, Barrett MS, et al. Prevalence, attitudes, and behaviors related to the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in student athletes. J Adolesc Health. 2002;30: 150-153.
11. Kujala UM, Sarna S, Kaprio J. Use of medications and dietary supplements in later years among male former top-level athletes. Arch Intern Med. 2003; 163: 1064-1068.
12. Stata Statistical Software [computer Program]. Version 8.0. College Station, TX: Stata Corporation; 2005.
13. Noel MB, VanHeest JL, Zaneteas P, et al. Body composition in division I football players. J Strength Cond Res. 2003;17: 228-237.
14. Rimm EB, Stampfer NJ, Giovannucci E, et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol. 1995;141: 1117-1127.
15. Winter Y, Rohrmann S, Linseisen J, et al. Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke. 2008;39: 3145-3151.